CARL ZEISS MEDITEC ADR 1 (AFXA) — Cash Flow Quality Index
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Cash Flow Quality Index of 2.78x as of September 2025. Operating cash flow of €144.16 Million exceeds net income of €51.81 Million, indicating high earnings quality where cash backs reported profits. Also explore AFXA total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CARL ZEISS MEDITEC ADR 1 Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CARL ZEISS MEDITEC ADR 1 (AFXA) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for CARL ZEISS MEDITEC ADR 1 (2022–2025)
Year-by-year earnings quality comparison for CARL ZEISS MEDITEC ADR 1. For live market cap and the full company financial profile, see market cap of CARL ZEISS MEDITEC ADR 1.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.49x | €209.86 Million | €141.21 Million | ▲ +7.4% |
| 2024 | 1.38x | €247.32 Million | €178.73 Million | ▲ +60.2% |
| 2023 | 0.86x | €250.86 Million | €290.40 Million | ▲ +34.9% |
| 2022 | 0.64x | €188.20 Million | €293.91 Million | — |